Advanced Micro Devices (NASDAQ: AMD) saw its stock climb 3.5% in after-hours trading on Tuesday after unveiling bold long-term growth targets during its Financial Analyst Day. The announcement followed a 2.6% decline during the regular session but quickly reignited investor optimism in the semiconductor giant’s future.
AMD revealed its goal to achieve more than 35% compound annual revenue growth (CAGR) over the next three to five years, supported by non-GAAP operating margins above 35% and non-GAAP earnings per share exceeding $20. The company’s strategy focuses on strengthening its leadership in data center and artificial intelligence (AI) technologies—two of the fastest-growing segments in the chip industry.
Chair and CEO Dr. Lisa Su emphasized AMD’s expanding opportunities, stating, “AMD is entering a new era of growth fueled by our leadership technology roadmaps and accelerating AI momentum. With our broad product portfolio and deep strategic partnerships, we are uniquely positioned to lead the next generation of high-performance and AI computing.”
The company highlighted significant traction in its data center division, projecting more than 60% revenue CAGR and targeting over 50% server CPU market share. AMD also aims for more than 80% CAGR in data center AI revenue, propelled by its Instinct GPU lineup. The Instinct MI350 Series GPUs have become AMD’s fastest-growing product line, already deployed by top cloud providers such as Oracle Cloud Infrastructure. The next-generation “Helios” systems powered by MI450 GPUs are expected to launch in the third quarter of 2026.
Beyond data centers, AMD anticipates exceeding 40% client revenue market share and sustaining over 10% revenue CAGR in its embedded, client, and gaming businesses. With a foundation of over one billion AMD-powered gaming devices, the company is positioning itself at the forefront of high-performance computing and AI innovation.


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



